skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Biological efficacy of a boronated porphyrin as measured in cell culture

Conference ·
OSTI ID:6801975

Attempts to develop a boronated porphyrin analog have suffered from problems associated with toxicity, solubility and, upon occasion, lability of the boron tag. One compound synthesized by one of us (SBK), designated ''SBK-II'', has evidently overcome the above problems, providing therapeutic amounts of boron in animal tumor models (20-40 ..mu..g B/g tumor) with retention times in the order of weeks. As is well known, biological efficacy will depend upon distribution within (or without) the cell. In the experiments detailed here, biological efficacy has been evaluated in Hamster V-79 cells, irradiated at the thermal neutron beam at the Brookhaven Medical Research Reactor, using irradiation geometries and techniques as described in detail elsewhere. Cell survival curves obtained with 15 and 29 ..mu..g /sup 10/B per ml from H/sub 3//sup 10/BO/sub 3/ (''ambient'' conditions) were compared to a control (no boron) curve (data not shown). 2 refs., 3 figs., 1 tab.

Research Organization:
Brookhaven National Lab., Upton, NY (USA)
DOE Contract Number:
AC02-76CH00016
OSTI ID:
6801975
Report Number(s):
BNL-41568; CONF-8705326-1; ON: DE88016578; TRN: 88-036035
Resource Relation:
Conference: 3. international symposium on neutron capture therapy, Bremen, F.R. Germany, 31 May 1987; Other Information: Portions of this document are illegible in microfiche products
Country of Publication:
United States
Language:
English